Caris Life Sciences (CAI) Other Non-Current Assets (2024 - 2026)

Caris Life Sciences' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 14.67% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 14.67% decrease from a year earlier, with the FY2025 full-year figure at $45.3 million, up 11.03% from the prior year.
• Other Non-Current Assets retreated to $3.5 million in Q1 2026 per CAI's latest filing, from $45.3 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $47.0 million in Q3 2025 and bottomed at $3.5 million in Q1 2026.
• The 3-year median for Other Non-Current Assets is $41.0 million (2024), against an average of $30.3 million.
• Across the five-year window, Other Non-Current Assets gained 11.03% in 2025 and declined 14.67% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $40.8 million in 2024, then rose by 11.03% to $45.3 million in 2025, then tumbled by 92.31% to $3.5 million in 2026.
• Per Business Quant, the three latest CAI Other Non-Current Assets figures stand at $3.5 million (Q1 2026), $45.3 million (Q4 2025), and $47.0 million (Q3 2025).